Cargando…

The Use of Bioactive Compounds in Hyperglycemia- and Amyloid Fibrils-Induced Toxicity in Type 2 Diabetes and Alzheimer’s Disease

It has become increasingly apparent that defective insulin signaling may increase the risk for developing Alzheimer’s disease (AD), influence neurodegeneration through promotion of amyloid formation or by increasing inflammatory responses to intraneuronal β-amyloid. Recent work has demonstrated that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lupaescu, Ancuta-Veronica, Iavorschi, Monica, Covasa, Mihai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879577/ https://www.ncbi.nlm.nih.gov/pubmed/35213966 http://dx.doi.org/10.3390/pharmaceutics14020235

Ejemplares similares

Innovative Materials with Possible Applications in the Wound Dressings Field: Alginate-Based Films with Moringa oleifera Extract
por: Gheorghita, Roxana, et al.
Publicado: (2023)

Cu and Zn Interactions with Peptides Revealed by High-Resolution Mass Spectrometry
por: Iavorschi, Monica, et al.
Publicado: (2022)

Zinc Binding to NAP-Type Neuroprotective Peptides: Nuclear Magnetic Resonance Studies and Molecular Modeling
por: Lupaescu, Ancuta-Veronica, et al.
Publicado: (2021)

Gut Microbiota and Complications of Type-2 Diabetes
por: Iatcu, Camelia Oana, et al.
Publicado: (2021)

Antiaggregation Potential of Padina gymnospora against the Toxic Alzheimer’s Beta-Amyloid Peptide (25–35) and Cholinesterase Inhibitory Property of Its Bioactive Compounds
por: Shanmuganathan, Balakrishnan, et al.
Publicado: (2015)

The Role of Matrix Metalloproteinases (MMP-8, MMP-9, MMP-13) in Periodontal and Peri-Implant Pathological Processes
por: Luchian, Ionut, et al.
Publicado: (2022)

Effects and Underlying Mechanisms of Bioactive Compounds on Type 2 Diabetes Mellitus and Alzheimer's Disease
por: Li, Rongzi, et al.
Publicado: (2019)

Natural bioactive compounds in Alzheimer's disease: From the perspective of type 3 diabetes mellitus
por: Huang, Juan, et al.
Publicado: (2023)

Dietary Patterns of Patients with Prediabetes and Type 2 Diabetes
por: Iatcu, Camelia Oana, et al.
Publicado: (2023)

Clindamycin as an Alternative Option in Optimizing Periodontal Therapy
por: Luchian, Ionut, et al.
Publicado: (2021)

Additive Toxicity of β-Amyloid by a Novel Bioactive Peptide In Vitro: Possible Implications for Alzheimer’s Disease
por: Garcia-Ratés, Sara, et al.
Publicado: (2013)

Formation of Toxic Amyloid Fibrils by Amyloid β-Protein on Ganglioside Clusters
por: Matsuzaki, Katsumi
Publicado: (2011)

Using Salivary MMP-9 to Successfully Quantify Periodontal Inflammation during Orthodontic Treatment
por: Luchian, Ionut, et al.
Publicado: (2021)

Toxic species in amyloid disorders: Oligomers or mature fibrils
por: Verma, Meenakshi, et al.
Publicado: (2015)

Microbiota Transplant in the Treatment of Obesity and Diabetes: Current and Future Perspectives
por: Napolitano, Michael, et al.
Publicado: (2020)

Editorial: Oligomerization and fibrillation of amyloid peptides: Mechanism, toxicity and inhibition
por: Qian, Zhenyu, et al.
Publicado: (2022)

Amyloid Peptide Toxicity in an Animal Model of Alzheimer Disease
por: Gross, Liza
Publicado: (2007)

Impaired Hyperglycemia-Induced Delay in Gastric Emptying in Patients With Type 1 Diabetes Deficient for Islet Amyloid Polypeptide
por: Woerle, Hans J., et al.
Publicado: (2008)

The Role of Selected Bioactive Compounds in the Prevention of Alzheimer’s Disease
por: Grodzicki, Wojciech, et al.
Publicado: (2020)

Disulfide Bonds Reduce the Toxicity of the Amyloid Fibrils Formed by an Extracellular Protein**
por: Mossuto, Maria F, et al.
Publicado: (2011)

Analysis of Toxic Amyloid Fibril Interactions at Natively Derived Membranes by Ellipsometry
por: Smith, Rachel A. S., et al.
Publicado: (2015)

Amyloid fibril proteomics of AD brains reveals modifiers of aggregation and toxicity
por: Upadhyay, Arun, et al.
Publicado: (2023)

Modulation of β-Amyloid Fibril Formation in Alzheimer’s Disease by Microglia and Infection
por: Brown, Madeleine R., et al.
Publicado: (2020)

4-Phenylbutyrate (PBA) treatment reduces hyperglycemia and islet amyloid in a mouse model of type 2 diabetes and obesity
por: de Pablo, Sara, et al.
Publicado: (2021)

Bioactive Compounds in Kimchi Improve the Cognitive and Memory Functions Impaired by Amyloid Beta
por: Woo, Minji, et al.
Publicado: (2018)

Unveiling the Therapeutic Potentials of Mushroom Bioactive Compounds in Alzheimer’s Disease
por: Li, Na, et al.
Publicado: (2023)

Molecular Structure of Amyloid Fibrils Controls the Relationship between Fibrillar Size and Toxicity
por: Lee, Young Jin, et al.
Publicado: (2011)

β-Amyloid Clustering around ASC Fibrils Boosts Its Toxicity in Microglia
por: Friker, Lea L., et al.
Publicado: (2020)

Tyrosine carbon dots inhibit fibrillation and toxicity of the human islet amyloid polypeptide
por: Bloch, Daniel Nir, et al.
Publicado: (2020)

Allium roseum L. extract inhibits amyloid beta aggregation and toxicity involved in Alzheimer’s disease
por: Boubakri, Abdelbasset, et al.
Publicado: (2020)

Nanoscale Flexibility Parameters of Alzheimer Amyloid Fibrils Determined by Electron Cryo-Microscopy**
por: Sachse, Carsten, et al.
Publicado: (2010)

Structural Variation in Amyloid-β Fibrils from Alzheimer’s Disease Clinical Subtypes
por: Qiang, Wei, et al.
Publicado: (2017)

The Role of Structural Polymorphism in Driving the Mechanical Performance of the Alzheimer's Beta Amyloid Fibrils
por: Grasso, Gianvito, et al.
Publicado: (2019)

Changes in lipid membranes may trigger amyloid toxicity in Alzheimer's disease
por: Drolle, Elizabeth, et al.
Publicado: (2017)

Fasting and Postprandial Hyperglycemia: Their Predictors and Contributions to Overall Hyperglycemia in Korean Patients with Type 2 Diabetes
por: Moon, Jaecheol, et al.
Publicado: (2020)

Natural Bioactive Compounds from Food Waste: Toxicity and Safety Concerns
por: Vilas-Boas, Ana A., et al.
Publicado: (2021)

Anion Gap Toxicity in Alloxan Induced Type 2 Diabetic Rats Treated with Antidiabetic Noncytotoxic Bioactive Compounds of Ethanolic Extract of Moringa oleifera
por: Omabe, Maxwell, et al.
Publicado: (2014)

Bioactive Compounds and Volatile Profiles of Five Transylvanian Wild Edible Mushrooms
por: Fogarasi, Melinda, et al.
Publicado: (2018)

Structural Reorganisation and Potential Toxicity of Oligomeric Species Formed during the Assembly of Amyloid Fibrils
por: Cheon, Mookyung, et al.
Publicado: (2007)

Identification of the primary peptide contaminant that inhibits fibrillation and toxicity in synthetic amyloid-β42
por: Adams, Daniel J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k8l66lm0nvj4fsgi9u7jkbl5kg